Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 113

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 113
---
4 |     |   |    2023 |
|:-----------------------------|:----|:--------------|--------:|:----|:--|--------:|
| Current income tax provision |     | $             | 139,634 |     | $ | 199,989 |
| Deferred income tax          |     |               |   1,983 |     |   |   5,196 |
| Total income taxes expenses  |     | $             | 141,617 |     | $ | 205,185 |

We generated substantially all of our taxable income in Hong Kong and no taxable income. The deferred tax assets mainly represented temporary differences arising from acceleration of depreciation on property and equipment and impairment for inventories. Our effective income tax rate was 15.8% and 15.4% for the years ended March 31, 2024 and 2023, respectively. The slightly increase in our effective income tax rate was due to (i) non-deductible expense relating to unqualified donation contributing 0.6% increase in effective income tax rate.

Net income

As a result of the foregoing, we reported a net income of $753,429 and $1,129,504 for the years ended March 31, 2024 and 2023, respectively.

<div align='center'>62</div>

For the Six Months Ended September 30, 2024 and 2023

The following table summarizes the results
of our operations for the six months ended September 30, 2024 and 2023, respectively, and provides information regarding the dollar and
percentage change during such periods.

|                                   |     | For the six months ended September 
 30,                                |       2024 |   |     |   |       2023 |   |     | Variance |   Amount |   |     |     |         % |    |
|:----------------------------------|:----|:-----------------------------------|-----------:|:--|:----|:--|-----------:|:--|:----|:---------|---------:|:--|:----|:----|----------:|:---|
| Revenue                           |     | $                                  |  4,077,598 |   |     | $ |  4,401,304 |   |     | $        | (323,706 | ) |     |     |      (7.4 | )% |
| Cost of revenue                   |     |